This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

4 Stocks Under $10 With Big Upside Potential

Stocks in this article: BRCDAMRNSHORLEI

Amarin

Another under-$10 stock that looks poised for higher prices is biotechnology and drug maker is Amarin (AMRN). This is a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease. This stock has dropped around 12.4% so far in 2011.

If you take a look at the chart for Amarin, you'll notice that this stock has been downtrending big for the last couple of months, with shares consistently making lower highs and lower lows. Whenever any stock shows a price pattern like of lower highs and lows, it's always considered bearish behavior. Shares of Amarin were trading as high as $15.02 in July but have since then dropped to a recent low of $6.43. Since hitting that low, the stock has started to rebound and is now approaching a breakout trade if it can manage to move above some past overhead resistance levels.

Trades should now watch for a sustained move and close on high-volume above some overhead resistance at $7.34 a share. A high-volume move and close above that level should set this stock up for a big bounce back towards its 50-day moving average of $8.77, or possibly much higher towards its 200-day moving average of $11.45.

One could now be a buyer of this stock off any noticeable weakness with a stop just below some near-term support at $6.43. You could also be a buyer off of strength and get long once $7.34 is taken out with volume. Look for volume that's tracking in close to or above its three-month average action of 2.49 million shares.

Amarin shows up on a recent list of 10 Biotech Stocks Loved and Hated by the Pros.

3 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs